150 related articles for article (PubMed ID: 2237810)
1. Cellular-phase fibrinolysis and coronary reperfusion during acute myocardial infarction: a study in patients receiving intravenous streptokinase-methylprednisolone therapy.
Langleben D; Moroz LA; Schlesinger RD
Thromb Res; 1990 Jul; 59(2):247-58. PubMed ID: 2237810
[TBL] [Abstract][Full Text] [Related]
2. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL
Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic treatment in acute myocardial infarction: neutrophil activation, peripheral leucocyte responses, and myocardial injury.
Ranjadayalan K; Umachandran V; Davies SW; Syndercombe-Court D; Gutteridge CN; Timmis AD
Br Heart J; 1991 Jul; 66(1):10-4. PubMed ID: 1854566
[TBL] [Abstract][Full Text] [Related]
6. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
7. Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase.
Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
J Am Coll Cardiol; 1994 Nov; 24(6):1445-52. PubMed ID: 7930274
[TBL] [Abstract][Full Text] [Related]
8. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
9. Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Fitzpatrick PG; Barry WH; Menlove RL; Rothbard RL; Anderson JL
Am Heart J; 1988 Oct; 116(4):903-14. PubMed ID: 3051985
[TBL] [Abstract][Full Text] [Related]
10. The effect of reperfusion on plasma tumor necrosis factor alpha and C reactive protein levels in the course of acute myocardial infarction.
Pudil R; Pidrman V; Krejsek J; Gregor J; Tichý M; Andrýs C; Drahosová M
Acta Medica (Hradec Kralove); 1996; 39(4):149-53. PubMed ID: 9270121
[TBL] [Abstract][Full Text] [Related]
11. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
[TBL] [Abstract][Full Text] [Related]
12. Combined thromboxane A2 synthase inhibition and prostaglandin endoperoxide receptor antagonism limits myocardial infarct size after mechanical coronary occlusion and reperfusion at doses enhancing coronary thrombolysis by streptokinase.
Vandeplassche G; Hermans C; Somers Y; Van de Werf F; de Clerck F
J Am Coll Cardiol; 1993 Apr; 21(5):1269-79. PubMed ID: 8459087
[TBL] [Abstract][Full Text] [Related]
13. [Relation between the systemic fibrinolytic status and coronary reperfusion during thrombolytic therapy with streptokinase of patients with acute myocardial infarction].
Markov VA; Stoliarov VA; Varvarenko VI; Cherniavskaia LI; Karpov RS
Kardiologiia; 1989 Sep; 29(9):92-4. PubMed ID: 2593482
[No Abstract] [Full Text] [Related]
14. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction.
Gore JM; Roberts R; Ball SP; Montero A; Goldberg RJ; Dalen JE
Am J Cardiol; 1987 Jun; 59(15):1234-8. PubMed ID: 3109227
[TBL] [Abstract][Full Text] [Related]
15. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
[TBL] [Abstract][Full Text] [Related]
16. Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Samama M; Conard J; Verdy E; van Dreden P; Nguyen G; Combrisson A; Acar J
Drugs; 1987; 33 Suppl 3():268-74. PubMed ID: 3315605
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study.
Munkvad S; Jespersen J; Gram J; Kluft C
J Am Coll Cardiol; 1991 Mar; 17(4):957-62. PubMed ID: 1900313
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment plasminogen activator inhibitor-1 (PAI-1) levels and the outcome of thrombolysis with streptokinase in patients with acute myocardial infarction.
Sinkovic A
Am Heart J; 1998 Sep; 136(3):406-11. PubMed ID: 9736130
[TBL] [Abstract][Full Text] [Related]
20. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
Monassier JP; Hanssen M
Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
